Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10032


Purpose:

The purpose of this project is to study ways to make it more likely that patients will take their blood pressure medicine as recommended by their doctors.


Study summary:

The objective of this randomized control trial is to evaluate, among 190 African-American patients with poorly controlled hypertension followed in a community-based primary care practice, whether motivational interviewing is more effective than usual care (routine counseling) in achieving adherence to prescribed blood pressure medications at 12 months. The project aims to: 1) determine whether patients who receive motivational interview counseling have greater reduction in both systolic and diastolic blood pressure than those in the control group at 12 months. Clinic blood pressure readings will be assessed at baseline and at every three months thereafter for one year and 2) assess the effect of self-efficacy and intrinsic motivation as potential mediators of motivational interview on adherence. Self-efficacy and intrinsic motivation will be assessed at baseline and every three months thereafter for one year.


Criteria:

Inclusion Criteria: The target population consisted of hypertensive African American patients who fulfilled the following eligibility criteria: - Self-identification as African American - Age 18 years or older - Diagnosis of hypertension utilizing ICD-9 codes 401-401.9 (the code for essential hypertension) - Taking at least one antihypertensive medication - Uncontrolled hypertension of a clinic blood pressure reading >140/90 mm Hg or 130/80 mm Hg (for those with kidney disease or diabetes) on two successive clinic visits prior to screening (defined per JNC VI criteria) - Fluent in English language Exclusion Criteria: Participants were excluded if they: - Had a diagnosis of cognitive impairment or serious medical condition as determined by their primary physician - Were unable to give informed consent - Refused to participate


NCT ID:

NCT00208104


Primary Contact:

Principal Investigator
Gbenga Ogedegbe, MD, MS, MPH
CUMC


Backup Contact:

N/A


Location Contact:

New York, New York 10032
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.